PharmStars inaugural graduate class of digital health companies flank CEO Naomi Fried (center, blue jacket) and GM Laura Gunn (center, black jacket)

Da­ta an­a­lyt­ics looms large as Pharm­Stars dig­i­tal health ac­cel­er­a­tor wraps first 'Phar­mU' start­up class

Class is dis­missed for Pharm­Stars’ first co­hort of dig­i­tal health start­up com­pa­nies. The phar­ma-fo­cused ac­cel­er­a­tor re­cent­ly grad­u­at­ed 12 com­pa­nies af­ter a 10-week ed­u­ca­tion­al pro­gram and a fi­nal show­case meet-up with six phar­ma mem­bers – Boehringer In­gel­heim, Eli Lil­ly, No­vo Nordisk, Sum­i­to­vant Bio­phar­ma, Take­da and Alex­ion (now part of As­traZeneca).

The fi­nal 12 – bumped up from an ini­tial ex­pect­ed class size of 10 af­ter 73 ap­pli­ca­tions poured in – are now in var­i­ous stages of talks with the phar­ma com­pa­nies about next steps. While it’s too ear­ly to re­port any fi­nal deals or part­ner­ships, Pharm­Stars’ founder and CEO Nao­mi Fried ap­plaud­ed first-round ef­forts and ex­pects there will be news in the up­com­ing weeks.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.